A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials study

INTRODUCTION: Lung cancer remains the leading cause of death from cancer, worldwide. Developing early detection diagnostic methods, especially non-invasive methods, is a critical component to raising the overall survival rate and prognosis for lung cancer. The purpose of this study is to evaluate tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Shai, Shafrira, Patolsky, Fernando, Drori, Hagai, Scheinman, Eyal J., Davidovits, Eyal, Davidovits, Giora, Tirman, Shoval, Arber, Nadir, Katz, Amit, Adir, Yochai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927051/
https://www.ncbi.nlm.nih.gov/pubmed/36788537
http://dx.doi.org/10.1186/s12931-023-02358-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927051/
https://www.ncbi.nlm.nih.gov/pubmed/36788537
http://dx.doi.org/10.1186/s12931-023-02358-w

Ejemplares similares